Clinical Trial Update: Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)

View source ↗

Summary

This clinical trial update summarizes completed results from a surveillance study of Revlimid (lenalidomide) in relapsed or refractory follicular lymphoma and m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Marginal Zone Lymphoma

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: Celgene | Conditions: Lymphoma Nonhodgkin | Status: COMPLETED